AAAAAA
Results:
1-12
|
Results: 12
Authors:
Fonseca, R
Oken, MM
Harrington, D
Bailey, RJ
Van Wier, SA
Henderson, KJ
Kay, NE
Van Ness, B
Greipp, PR
Dewald, GW
Citation: R. Fonseca et al., Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy, LEUKEMIA, 15(6), 2001, pp. 981-986
Authors:
Cheung, WC
Van Ness, B
Citation: Wc. Cheung et B. Van Ness, The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro, LEUKEMIA, 15(2), 2001, pp. 264-271
Authors:
Kay, NE
Leong, TL
Bone, N
Vesole, DH
Greipp, PR
Van Ness, B
Oken, MM
Kyle, RA
Citation: Ne. Kay et al., Blood levels of immune cells predict survival in myeloma patients: resultsof an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosedmultiple myeloma patients, BLOOD, 98(1), 2001, pp. 23-28
Authors:
Lin, XD
Linden, M
Van Ness, B
Citation: Xd. Lin et al., Induced kappa receptor editing shows no allelic preference in a mouse pre-B cell line, J IMMUNOL, 165(12), 2000, pp. 7058-7063
Authors:
Fonseca, R
Trendle, MC
Leong, T
Kyle, RA
Oken, MM
Kay, NE
Van Ness, B
Greipp, PR
Citation: R. Fonseca et al., Prognostic value of serum markers of bone metabolism in untreated multiplemyeloma patients, BR J HAEM, 109(1), 2000, pp. 24-29
Authors:
Rowley, M
Liu, PC
Van Ness, B
Citation: M. Rowley et al., Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan, BLOOD, 96(9), 2000, pp. 3175-3180
Authors:
Greipp, PR
Trendle, MC
Leong, T
Oken, MM
Kay, NE
Van Ness, B
Kyle, RA
Citation: Pr. Greipp et al., Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?, LEUK LYMPH, 35(1-2), 1999, pp. 83-89
Authors:
Kay, N
Leong, T
Kyle, RA
Greipp, P
Van Ness, B
Bone, N
Oken, MM
Citation: N. Kay et al., Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myelomapatients, a study of the Eastern Cooperative Oncology Group (E9487), LEUK LYMPH, 33(1-2), 1999, pp. 127-133
Authors:
Liu, P
Oken, M
Van Ness, B
Citation: P. Liu et al., Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis, LEUKEMIA, 13(3), 1999, pp. 473-480
Authors:
Liu, XD
Van Ness, B
Citation: Xd. Liu et B. Van Ness, Gene targeting of the KI-KII sequence elements in a model pre-B cell line:effects on germline transcription and rearrangement of the kappa locus, MOL IMMUNOL, 36(7), 1999, pp. 461-469
Authors:
Liu, XD
Prabhu, A
Van Ness, B
Citation: Xd. Liu et al., Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3 ' enhancer that affect synergy with the intron enhancer, J BIOL CHEM, 274(6), 1999, pp. 3285-3293
Authors:
Oken, MM
Leong, T
Lenhard, RE
Greipp, PR
Kay, NE
Van Ness, B
Keimowitz, RM
Kyle, RA
Citation: Mm. Oken et al., The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma - Phase III Eastern Cooperative Oncology Group clinical trial EST 9486, CANCER, 86(6), 1999, pp. 957-968
Risultati:
1-12
|